List view / Grid view
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
21 February 2019 | By European Pharmaceutical Review
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
20 February 2019 | By European Pharmaceutical Review
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
20 February 2019 | By Eurofins CDMO
Eurofins CDMO provides full suite of drug development services encompassing development of the bioprocesses, formulation screening, analytical development, pre-clinical testing, sterile and non-sterile bio-manufacturing of clinical trial batches and orphan drugs.
19 February 2019 | By European Pharmaceutical Review
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
19 February 2019 | By Sciex
Antibody-drug conjugates (ADC’s) are targeted cancer therapeutics that deliver a cytotoxic agent, the payload, to the tumor.
18 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
15 February 2019 | By European Pharmaceutical Review
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
15 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
14 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
A collaboration between Brigham and Women's Hospital and Vanderbilt University Medical Center looks to advance the application of AI in health...
13 February 2019 | By European Pharmaceutical Review
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
13 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
11 February 2019 | By European Pharmaceutical Review
Researchers have identified a method of improving the performance of infrared imaging techniques which could be useful in medical applications...
8 February 2019 | By European Pharmaceutical Review
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
7 February 2019 | By European Pharmaceutical Review
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
Follow: